BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 32392927)

  • 1. [Ovarian Sertoli-Leydig cell tumors: DICER1 hotspot mutations and associated clinicopathological features].
    Xiao YX; Zhu XL; Bi R; Tu XY; Cheng YF; Chang B; Yu L; Huang D; Lu YM; Shan L; Yang WT
    Zhonghua Bing Li Xue Za Zhi; 2020 May; 49(5):441-447. PubMed ID: 32392927
    [No Abstract]   [Full Text] [Related]  

  • 2. DICER1 hotspot mutations in ovarian Sertoli-Leydig cell tumors: a potential association with androgenic effects.
    Kato N; Kusumi T; Kamataki A; Tsunoda R; Fukase M; Kurose A
    Hum Pathol; 2017 Jan; 59():41-47. PubMed ID: 27664536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DICER1-related Sertoli-Leydig cell tumor and gynandroblastoma: Clinical and genetic findings from the International Ovarian and Testicular Stromal Tumor Registry.
    Schultz KAP; Harris AK; Finch M; Dehner LP; Brown JB; Gershenson DM; Young RH; Field A; Yu W; Turner J; Cost NG; Schneider DT; Stewart DR; Frazier AL; Messinger Y; Hill DA
    Gynecol Oncol; 2017 Dec; 147(3):521-527. PubMed ID: 29037807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DICER1 and FOXL2 mutations in ovarian sex cord-stromal tumours: a GINECO Group study.
    Goulvent T; Ray-Coquard I; Borel S; Haddad V; Devouassoux-Shisheboran M; Vacher-Lavenu MC; Pujade-Laurraine E; Savina A; Maillet D; Gillet G; Treilleux I; Rimokh R
    Histopathology; 2016 Jan; 68(2):279-85. PubMed ID: 26033501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A survey of DICER1 hotspot mutations in ovarian and testicular sex cord-stromal tumors.
    Conlon N; Schultheis AM; Piscuoglio S; Silva A; Guerra E; Tornos C; Reuter VE; Soslow RA; Young RH; Oliva E; Weigelt B
    Mod Pathol; 2015 Dec; 28(12):1603-12. PubMed ID: 26428316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of FOXL2, SOX9, and β-catenin expression and DICER1 mutation in differentiating sex cord tumor with annular tubules from other sex cord tumors of the ovary.
    Onder S; Hurdogan O; Bayram A; Yilmaz I; Sozen H; Yavuz E
    Virchows Arch; 2021 Aug; 479(2):317-324. PubMed ID: 33566167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DICER1 and FOXL2 Mutation Status Correlates With Clinicopathologic Features in Ovarian Sertoli-Leydig Cell Tumors.
    Karnezis AN; Wang Y; Keul J; Tessier-Cloutier B; Magrill J; Kommoss S; Senz J; Yang W; Proctor L; Schmidt D; Clement PB; Gilks CB; Huntsman DG; Kommoss F
    Am J Surg Pathol; 2019 May; 43(5):628-638. PubMed ID: 30986800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The oncogenic roles of DICER1 RNase IIIb domain mutations in ovarian Sertoli-Leydig cell tumors.
    Wang Y; Chen J; Yang W; Mo F; Senz J; Yap D; Anglesio MS; Gilks B; Morin GB; Huntsman DG
    Neoplasia; 2015 Aug; 17(8):650-60. PubMed ID: 26408257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DICER1 Mutations Are Consistently Present in Moderately and Poorly Differentiated Sertoli-Leydig Cell Tumors.
    de Kock L; Terzic T; McCluggage WG; Stewart CJR; Shaw P; Foulkes WD; Clarke BA
    Am J Surg Pathol; 2017 Sep; 41(9):1178-1187. PubMed ID: 28654427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Application of molecular analysis in differential diagnosis of ovarian adult granulosa cell tumors].
    Zheng XZ; Ma JH; Chen TB; Xu F; Zou ZY; Zhang LH; Jin YL; Zhan Y
    Zhonghua Bing Li Xue Za Zhi; 2020 Aug; 49(8):794-799. PubMed ID: 32746545
    [No Abstract]   [Full Text] [Related]  

  • 11. Testicular Neoplasms With Sex Cord and Stromal Components Harbor a Recurrent Pattern of Chromosomal Gains.
    Acosta AM; Sholl LM; Maclean F; Kao CS; Ulbright TM
    Mod Pathol; 2024 Jan; 37(1):100368. PubMed ID: 37871653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DICER1 mutations in familial multinodular goiter with and without ovarian Sertoli-Leydig cell tumors.
    Rio Frio T; Bahubeshi A; Kanellopoulou C; Hamel N; Niedziela M; Sabbaghian N; Pouchet C; Gilbert L; O'Brien PK; Serfas K; Broderick P; Houlston RS; Lesueur F; Bonora E; Muljo S; Schimke RN; Bouron-Dal Soglio D; Arseneau J; Schultz KA; Priest JR; Nguyen VH; Harach HR; Livingston DM; Foulkes WD; Tischkowitz M
    JAMA; 2011 Jan; 305(1):68-77. PubMed ID: 21205968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ovarian sex cord-stromal tumors, pleuropulmonary blastoma and DICER1 mutations: a report from the International Pleuropulmonary Blastoma Registry.
    Schultz KA; Pacheco MC; Yang J; Williams GM; Messinger Y; Hill DA; Dehner LP; Priest JR
    Gynecol Oncol; 2011 Aug; 122(2):246-50. PubMed ID: 21501861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Well-differentiated Sertoli-Leydig Cell Tumors (SLCTs) Are Not Associated With DICER1 Pathogenic Variants and Represent a Different Tumor Type to Moderately and Poorly Differentiated SLCTs.
    McCluggage WG; Rivera B; Chong AS; Clarke BA; Schultz KAP; Dehner LP; Tchrakian N; Apellaniz-Ruiz M; Gilks CB; Kommoss F; Stewart CJR; Foulkes WD
    Am J Surg Pathol; 2023 Apr; 47(4):490-496. PubMed ID: 36583307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pediatric Sertoli-Leydig Cell Tumors of the Ovary: An Integrated Study of Clinicopathological Features, Pan-cancer-Targeted Next-generation Sequencing and Chromosomal Microarray Analysis From a Single Institution.
    Yang B; Chour W; Salazar CG; Zamiara P; Schmidt RJ; Raca G; Shillingford N; Zhou S; Warren M; Parham DM; Pawel B; Wang LL
    Am J Surg Pathol; 2024 Feb; 48(2):194-203. PubMed ID: 37946548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Characteristics and Mutation Analyses of Ovarian Sertoli-Leydig Cell Tumors.
    Yuan Z; Huo X; Jiang D; Yu M; Cao D; Wu H; Shen K; Yang J; Zhang Y; Zhou H; Wang Y
    Oncologist; 2020 Sep; 25(9):e1396-e1405. PubMed ID: 32557933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sertoli-Leydig cell tumor in two siblings with DICER1 syndrome: A case report and literature review.
    Zhang Y; Ren M; Hong Y; Zhong Y; Cong X; Chen C; Liu Z; Man Y; Yang L
    Medicine (Baltimore); 2020 Jul; 99(27):e20806. PubMed ID: 32629665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review on Sertoli-Leydig Cell Tumours of the Ovary.
    Muscat C; Calleja-Agius J
    Discov Med; 2024 Feb; 36(181):234-247. PubMed ID: 38409829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bilateral Ovarian Sertoli-Leydig Cell Tumors Harboring
    Hughes CE; Liang J; Paulson V; Wang H
    Fetal Pediatr Pathol; 2023 Jun; 42(3):472-478. PubMed ID: 36121434
    [No Abstract]   [Full Text] [Related]  

  • 20. Mesenteric extraovarian Sertoli-Leydig cell tumor without DICER1 hotspot mutation: a case report.
    Osakabe M; Sato C; Suzuki M; Sugimoto R; Fujita Y; Uesugi N; Ishida K; Itamochi H; Baba T; Sugai T
    Diagn Pathol; 2019 Apr; 14(1):27. PubMed ID: 30935425
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.